Plus: How AI can make it easier to find drugs from nature and a study suggests Ozempic could treat alcoholism.

Ipsen to present new data on elafibranor at The Liver Meeting® 2024Launch of Iqirvo® (elafibranor)1 on track with ...

Our team is now focused on the successful execution of our Phase 3 HAE clinical studies.” Recent Highlights and Clinical Study Updates Development Pipeline Upcoming Investor Events and Presentations ...

LOUISVILLE, Ky. -- More than half of patients with newly diagnosed metastatic kidney cancer responded to a novel drug ...

Humacyte, Inc. recently announced the presentation of results from the V007 phase 3 clinical trial of the company’s acel ...

In the final part of our interview, Ticiana Leal, MD, Winship Cancer Institute, looks to the future of perioperative care in the non–small cell lung cancer (NSCLC) arena and the importance of risk ...

WINT Enrolling SCAI Stage C participants in SEISMiC C trial, preparing for Phase 3 readiness Pennsylvania-based Windtree ...

Their Phase 2 MOMENTUM trial for obesity demonstrated significant ... Thus, despite its concentration, regulatory, and ...

And also we found the significant effects in terms of ADAS-Cog [Alzheimer's Disease Assessment Scale-Cognitive Subscale], ...

Following patient deaths in a lupus trial that led to the termination of that program, Kezar’s autoimmune candidate ...

Longboard Pharmaceuticals has commenced the Phase III DEEp OCEAN Study of its investigational oral drug bexicaserin for ...

Establishing growing body of preclinical data evaluating the DNase-based oncology platform across a number of high-value ...